Amikacin 100 Mg Inj

Amikacin works by binding to the bacterial ribosome, disrupting protein synthesis and effectively killing susceptible bacteria. As an aminoglycoside, it is particularly effective against gram-negative organisms, including many strains resistant to other antibiotic classes, making it a valuable option for serious or hospital-acquired infections where resistance is a concern.

The injection is commonly used to treat septicemia, complicated urinary tract infections, respiratory tract infections, bone and joint infections, skin and soft tissue infections, intra-abdominal infections, and burns or post-surgical wound infections. It is often reserved for more severe cases or used in combination with other antibiotics when a broader or synergistic effect is needed, particularly in critically ill or ICU patients.

Administered via intramuscular or intravenous injection under medical supervision, dosing is calculated based on body weight, renal function, and infection severity, since Amikacin carries a risk of nephrotoxicity (kidney impairment) and ototoxicity (hearing/balance impairment) with prolonged or high-dose use. Regular monitoring of kidney function and drug levels is typically recommended during treatment, especially in patients with pre-existing renal impairment or in extended courses.